scorecardresearch
Follow Us:
Tuesday, August 09, 2022

Can aspirin reduce cancer mortality?

A recent Lancet study has indicated that aspirin could "prevent tumour development and metastasis, leading to reduced cancer mortality".

By: Lifestyle Desk | New Delhi |
September 3, 2019 5:46:44 pm
aspirin, cancer, lancet study, liver cancer, effects of aspirin, side effects of aspirin, uses of aspirin, benefits of aspirin, aspirin uses, indian express, indian express news Essentially, the trial was conducted to investigate whether taking aspirin daily for five years, after receiving standard therapy, can prevent the cancer from returning. (Source: File Photo)

Aspirin, or acetylsalicylic acid, is a household item. For ages, doctors have prescribed aspirin as medication to treat pain, fever and inflammation. It is often suggested that an aspirin being given immediately after a heart attack reduces the risk of death. When there’s a blood clot, your doctor may advise you take a low dose of aspirin to prevent it. Normally, patients who have undergone surgeries on clogged arteries, are directed to use aspirin as a blood thinner to prevent clots from forming.

Toothaches, common cold or mild headaches, an aspirin is a remedy for many common ailments. Now, a recent Lancet study has indicated that aspirin could “prevent tumour development and metastasis, leading to reduced cancer mortality, particularly for gastro-oesophageal (cancer of the point between the food pipe and stomach) and colorectal cancer (cancer of the colon or rectum)”.

ALSO READ | Flu vaccination linked to lower risk of death in patients with high BP, says study

Between 2015 and 2017, the effect of the daily aspirin on recurrence and survival after radical cancer therapy, was conducted in four tumour cohorts — gastro-oesophageal, colorectal, breast and prostate cancer. The study — known as the Add-Aspirin randomised trial — found that aspirin is well-tolerated after radical cancer therapy.

Subscriber Only Stories
Delhi Confidential: Raghav Chadha strikes a lyrical note as he bids farew...Premium
PM’s Office declares assets of Ministers, Modi donates share in only prop...Premium
9 FIRs, many notices: Shrikant Tyagi’s long record of notorietyPremium
Post pandemic, employees reluctant to return, firms take offices to small...Premium

For the study, 3,494 participants were registered — 115 in the gastro-oesophageal cancer cohort, 950 in the colorectal cancer cohort, 1,675 in the breast cancer cohort, and 754 in the prostate cancer cohort.

Essentially, the trial was conducted to investigate whether taking aspirin daily for five years, after receiving standard therapy, can prevent the cancer from returning.

ALSO READ | Household air pollution leading cause of cardiovascular disease in high-income countries

📣 The above article is for information purposes only and is not intended to be a substitute for professional medical advice. Always seek the guidance of your doctor or other qualified health professional for any questions you may have regarding your health or a medical condition.

For all the latest Lifestyle News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
First published on: 03-09-2019 at 05:46:44 pm

Featured Stories

Advertisement
Advertisement
Advertisement
Advertisement